RxDoctor Payments Data

Patrick Sanvanson, MD

Gastroenterology · Milwaukee, WINPI 1043472731

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $37,497 of the $39,555 with a category attached, or 94.8%. Sanofi accounts for 78.7% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $23,023 and has fallen 89.3% since, to $2,470 in 2025. Among gastroenterology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,555in general payments, 2019–2025

Across 28 payments — averaging $1412.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$31K
  • Regeneron Healthcare Solutions, Inc.$5K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
$50,565in research payments, 2019–2025

Across 5 payments — averaging $10,113 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$51K

What the payments were for

  • Speaking & faculty fees$37,49795%
  • Travel & lodging$1,1053%
  • Food & beverage$9532%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,555 in reported general payments places this provider in the 95th percentile of 285 gastroenterology providers in Wisconsin.

See all gastroenterology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$43,056
Medicare patients
241
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide41$40,806
XifaxanRifaximin15$36,572
KonvomepOmeprazole/Sodium Bicarbonate15$23,315
Rabeprazole Sodium39$2,002
Lubiprostone20$1,792
Ondansetron OdtOndansetron19$1,357
Omeprazole72$1,182
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl48$655
Pantoprazole Sodium35$624
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl26$449
Famotidine15$394
Dicyclomine Hcl11$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$3,000$36,57215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 285 gastroenterology providers in Wisconsin.

Other gastroenterology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →